JP Stock MarketDetailed Quotes

190A Chordia Therapeutics

Watchlist
  • 255
  • +18+7.59%
20min DelayMarket Closed Dec 13 15:30 JST
17.37BMarket Cap-8.20P/E (Static)

Chordia Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(FY)Aug 31, 2022
(FY)Aug 31, 2021
Total revenue
0
0
2.5B
0
0
800M
Cost of revenue
-24.89%1.5B
515.34M
2B
Gross profit
-398.07%-1.5B
-515.34M
503.18M
Operating expense
3.60%301.6M
107.14%105.23M
-84.09%291.12M
-1.47B
22.97%1.83B
1.49B
Selling and administrative expenses
----
----
----
----
9.66%188M
--171.44M
-Selling and marketing expense
----
----
----
----
9.66%188M
--171.44M
Research and development costs
----
----
----
----
25.18%1.66B
--1.32B
Total other operating income
----
----
----
----
119.45%14.56M
--6.64M
Operating profit
-949.48%-1.8B
-18.51%-620.57M
111.59%212.06M
-523.63M
-166.02%-1.83B
-687.76M
Net non-operating interest income (expenses)
-8.75M
0
Total other finance cost
--8.75M
----
----
----
----
----
Net investment income
70.59%-3.6M
133.43%2.96M
-374.53%-12.24M
-8.85M
-729.58%-2.58M
-311K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
-142.25%-10.96M
-374.93%-22.68M
-53.24%25.95M
8.25M
-65.93%55.49M
162.86M
Income before tax
-908.25%-1.82B
-23.81%-649.04M
112.71%225.76M
-524.23M
-238.27%-1.78B
-525.21M
Income tax
0.00%2.42M
0.00%605K
0.00%2.42M
605K
27.37%2.42M
1.9M
Net income
-918.09%-1.83B
-23.78%-649.65M
112.55%223.34M
-524.84M
-237.51%-1.78B
-527.11M
Net income continuous operations
-918.09%-1.83B
-23.78%-649.65M
112.55%223.34M
---524.84M
-237.51%-1.78B
---527.11M
Noncontrolling interests
Net income attributable to the company
-918.09%-1.83B
-23.78%-649.65M
112.55%223.34M
-524.84M
-237.51%-1.78B
-527.11M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
Net income attributable to common stockholders
-918.09%-1.83B
-23.78%-649.65M
112.55%223.34M
-524.84M
-237.51%-1.78B
-527.11M
Gross dividend payment
Basic earnings per share
-885.61%-31.11
-10.22%-10.2489
112.56%3.96
-9.2984
-237.51%-31.5191
-9.3386
Diluted earnings per share
-885.61%-31.11
-10.22%-10.2489
112.56%3.96
-9.2984
-237.51%-31.5191
-9.3386
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Aug 31, 2024(Q4)Aug 31, 2024(FY)Aug 31, 2023(Q4)Aug 31, 2023(FY)Aug 31, 2022(FY)Aug 31, 2021
Total revenue 002.5B00800M
Cost of revenue -24.89%1.5B515.34M2B
Gross profit -398.07%-1.5B-515.34M503.18M
Operating expense 3.60%301.6M107.14%105.23M-84.09%291.12M-1.47B22.97%1.83B1.49B
Selling and administrative expenses ----------------9.66%188M--171.44M
-Selling and marketing expense ----------------9.66%188M--171.44M
Research and development costs ----------------25.18%1.66B--1.32B
Total other operating income ----------------119.45%14.56M--6.64M
Operating profit -949.48%-1.8B-18.51%-620.57M111.59%212.06M-523.63M-166.02%-1.83B-687.76M
Net non-operating interest income (expenses) -8.75M0
Total other finance cost --8.75M--------------------
Net investment income 70.59%-3.6M133.43%2.96M-374.53%-12.24M-8.85M-729.58%-2.58M-311K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses) -142.25%-10.96M-374.93%-22.68M-53.24%25.95M8.25M-65.93%55.49M162.86M
Income before tax -908.25%-1.82B-23.81%-649.04M112.71%225.76M-524.23M-238.27%-1.78B-525.21M
Income tax 0.00%2.42M0.00%605K0.00%2.42M605K27.37%2.42M1.9M
Net income -918.09%-1.83B-23.78%-649.65M112.55%223.34M-524.84M-237.51%-1.78B-527.11M
Net income continuous operations -918.09%-1.83B-23.78%-649.65M112.55%223.34M---524.84M-237.51%-1.78B---527.11M
Noncontrolling interests
Net income attributable to the company -918.09%-1.83B-23.78%-649.65M112.55%223.34M-524.84M-237.51%-1.78B-527.11M
Preferred stock dividends
Other under preferred stock dividend 000000
Net income attributable to common stockholders -918.09%-1.83B-23.78%-649.65M112.55%223.34M-524.84M-237.51%-1.78B-527.11M
Gross dividend payment
Basic earnings per share -885.61%-31.11-10.22%-10.2489112.56%3.96-9.2984-237.51%-31.5191-9.3386
Diluted earnings per share -885.61%-31.11-10.22%-10.2489112.56%3.96-9.2984-237.51%-31.5191-9.3386
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Heat List
JP
Overall
Symbol
Price
% Chg

No Data